+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Polycystic Ovary Syndrome"

From
Dysmenorrhea Market Report and Forecast 2024-2032 - Product Thumbnail Image

Dysmenorrhea Market Report and Forecast 2024-2032

  • Report
  • February 2024
  • 180 Pages
  • Global
From
Gynaecology Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Gynaecology Drugs Market Report and Forecast 2023-2031

  • Report
  • July 2023
  • 140 Pages
  • Global
From
Contraceptive Pills Market Report and Forecast 2023-2031 - Product Thumbnail Image

Contraceptive Pills Market Report and Forecast 2023-2031

  • Report
  • April 2023
  • 147 Pages
  • Global
From
Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape - Product Thumbnail Image

Polycystic Ovarian Syndrome (PCOS) - Competitive Landscape

  • Report
  • March 2024
  • 77 Pages
  • Global
From
From
Loading Indicator

Polycystic Ovary Syndrome (PCOS) is a common endocrine disorder affecting women of reproductive age. It is characterized by a hormonal imbalance, which can lead to irregular menstrual cycles, infertility, and other physical and psychological symptoms. PCOS is also associated with an increased risk of developing type 2 diabetes, cardiovascular disease, and endometrial cancer. PCOS is a major public health concern, as it affects an estimated 5-10% of women of reproductive age worldwide. Diagnosis and management of PCOS can be challenging due to its complex and varied symptoms. Treatment typically involves lifestyle modifications, such as diet and exercise, as well as medications to regulate hormones and reduce symptoms. The PCOS market is a growing segment of the women's health industry, with a range of products and services available to diagnose and manage the condition. Companies in the PCOS market include pharmaceutical companies, medical device manufacturers, and digital health companies. Examples include AbbVie, Bayer, and Ovascience. Show Less Read more